Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

4,157 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Safety and efficacy of high-dose cytarabine MEAM therapy and other treatments for auto-peripheral blood stem cell transplantation: A retrospective comparative study.
Yui S, Wakita S, Nagata Y, Kuribayashi Y, Asayama T, Fujiwara Y, Sakaguchi M, Yamanaka S, Marumo A, Omori I, Kinoshita R, Onai D, Sunakawa M, Kaito Y, Inai K, Tokura T, Takeyoshi A, Yasuda S, Honma S, Nakayama K, Hirakawa T, Arai K, Kitano T, Okamoto M, Inokuchi K, Yamaguchi H. Yui S, et al. Among authors: fujiwara y. Asia Pac J Clin Oncol. 2023 Feb;19(1):136-148. doi: 10.1111/ajco.13780. Epub 2022 May 22. Asia Pac J Clin Oncol. 2023. PMID: 35599446
Risk Factors for Acute Kidney Injury and Chronic Kidney Disease following Allogeneic Hematopoietic Stem Cell Transplantation for Hematopoietic Malignancies.
Sakaguchi M, Nakayama K, Yamaguchi H, Mii A, Shimizu A, Inai K, Onai D, Marumo A, Omori I, Yamanaka S, Fujiwara Y, Fukunaga K, Ryotokuji T, Hirakawa T, Okabe M, Tamai H, Okamoto M, Wakita S, Yui S, Tsuruoka S, Inokuchi K. Sakaguchi M, et al. Among authors: fujiwara y. Acta Haematol. 2020;143(5):452-464. doi: 10.1159/000504354. Epub 2019 Dec 10. Acta Haematol. 2020. PMID: 31822013
Outcomes of Patients with Early Hyperbilirubinemia after Allogeneic Hematopoietic Stem Cell Transplantation.
Omori I, Yamaguchi H, Hirakawa T, Inai K, Onai D, Marumo A, Yamanaka S, Sakaguchi M, Fujiwara Y, Wakita S, Okamoto M, Tamai H, Nakayama K, Yui S, Inokuchi K. Omori I, et al. Among authors: fujiwara y. J Nippon Med Sch. 2020 Jul 13;87(3):142-152. doi: 10.1272/jnms.JNMS.2020_87-404. Epub 2020 Jan 31. J Nippon Med Sch. 2020. PMID: 32009070 Free article.
Presence of Promyelocytes in Peripheral Blood as a Novel Predictor of Optimal Timing for Single-Step Peripheral Blood Stem Cell Collection.
Marumo A, Yamaguchi H, Hirakawa T, Inai K, Onai D, Omori I, Yamanaka S, Fujiwara Y, Sakaguchi M, Wakita S, Okamoto M, Yui S, Inokuchi K. Marumo A, et al. Among authors: fujiwara y. J Nippon Med Sch. 2021 Mar 11;88(1):45-53. doi: 10.1272/jnms.JNMS.2021_88-104. Epub 2020 Mar 31. J Nippon Med Sch. 2021. PMID: 32238739 Free article.
Clinical characteristics and prognosis of acute myeloid leukemia associated with DNA-methylation regulatory gene mutations.
Ryotokuji T, Yamaguchi H, Ueki T, Usuki K, Kurosawa S, Kobayashi Y, Kawata E, Tajika K, Gomi S, Kanda J, Kobayashi A, Omori I, Marumo A, Fujiwara Y, Yui S, Terada K, Fukunaga K, Hirakawa T, Arai K, Kitano T, Kosaka F, Tamai H, Nakayama K, Wakita S, Fukuda T, Inokuchi K. Ryotokuji T, et al. Among authors: fujiwara y. Haematologica. 2016 Sep;101(9):1074-81. doi: 10.3324/haematol.2016.143073. Epub 2016 May 31. Haematologica. 2016. PMID: 27247325 Free PMC article.
Usefulness of BCOR gene mutation as a prognostic factor in acute myeloid leukemia with intermediate cytogenetic prognosis.
Terada K, Yamaguchi H, Ueki T, Usuki K, Kobayashi Y, Tajika K, Gomi S, Kurosawa S, Saito R, Furuta Y, Miyadera K, Tokura T, Marumo A, Omori I, Sakaguchi M, Fujiwara Y, Yui S, Ryotokuji T, Arai K, Kitano T, Wakita S, Fukuda T, Inokuchi K. Terada K, et al. Among authors: fujiwara y. Genes Chromosomes Cancer. 2018 Aug;57(8):401-408. doi: 10.1002/gcc.22542. Genes Chromosomes Cancer. 2018. PMID: 29663558
Importance of prognostic stratification via gene mutation analysis in elderly patients with acute myelogenous leukemia.
Fujiwara Y, Yamaguchi H, Yui S, Tokura T, Inai K, Onai D, Omori I, Marumo A, Yamanaka S, Sakaguchi M, Terada K, Nakagome S, Arai K, Kitano T, Okabe M, Okamoto M, Tamai H, Nakayama K, Tajika K, Wakita S, Inokuchi K. Fujiwara Y, et al. Int J Lab Hematol. 2019 Aug;41(4):461-471. doi: 10.1111/ijlh.13025. Epub 2019 Apr 10. Int J Lab Hematol. 2019. PMID: 30970181 Clinical Trial.
The sensitivity of the FLT3-ITD detection method is an important consideration when diagnosing acute myeloid leukemia.
Sakaguchi M, Nakajima N, Yamaguchi H, Najima Y, Shono K, Marumo A, Omori I, Fujiwara Y, Terada K, Yui S, Wakita S, Mitaya M, Arai K, Kitano T, Doki N, Ohashi K, Inokuchi K. Sakaguchi M, et al. Among authors: fujiwara y. Leuk Res Rep. 2020 Apr 19;13:100198. doi: 10.1016/j.lrr.2020.100198. eCollection 2020. Leuk Res Rep. 2020. PMID: 32368486 Free PMC article.
Full-length mutation search of the TP53 gene in acute myeloid leukemia has increased significance as a prognostic factor.
Terada K, Yamaguchi H, Ueki T, Usuki K, Kobayashi Y, Tajika K, Gomi S, Kurosawa S, Miyadera K, Tokura T, Omori I, Marumo A, Fujiwara Y, Yui S, Ryotokuji T, Osaki Y, Arai K, Kitano T, Kosaka F, Wakita S, Tamai H, Fukuda T, Inokuchi K. Terada K, et al. Among authors: fujiwara y. Ann Hematol. 2018 Jan;97(1):51-61. doi: 10.1007/s00277-017-3143-2. Epub 2017 Oct 4. Ann Hematol. 2018. PMID: 28980058
4,157 results